ilona maher glp 1 Glp1 Ilona Maher reveals the eating

Description

de Zeeuw, M.C

Zhao L, Cheng Z, Lu Y, et al

National Prescription Trends From 2024 To 2025 The national prescription trends for GLP-1s show a rapid and sustained increase in drug utilization

A.KapitzaC.MeierJ

[39] defined treatment (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, albiglutide) and control groups based on GLP-1 RA exposure: the treatment group included patients who initiated a GLP-1 RA within 6 months of IIH diagnosis, while the control group consisted of patients who never initiated a GLP-1 RA but were managed with conventional therapies such as acetazolamide, topiramate and furosemide